Bloomberg "Anywhere" Remote Login Bloomberg "Terminal" Request a Demo

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last $1.20 USD
Change Today +0.005 / 0.42%
Volume 17.4K
As of 10:15 AM 09/3/15 All times are local (Market data is delayed by at least 15 minutes).

mela sciences inc (MELA) Snapshot

Open
$1.19
Previous Close
$1.19
Day High
$1.20
Day Low
$1.18
52 Week High
03/11/15 - $4.05
52 Week Low
08/24/15 - $1.03
Market Cap
11.8M
Average Volume 10 Days
62.2K
EPS TTM
$-3.66
Shares Outstanding
9.9M
EX-Date
--
P/E TM
--
Dividend
--
Dividend Yield
--
Current Stock Chart for MELA SCIENCES INC (MELA)

Related News

No related news articles were found.

mela sciences inc (MELA) Related Businessweek News

No Related Businessweek News Found

mela sciences inc (MELA) Details

MELA Sciences, Inc., a medical device company, designs and develops software-driven technology for the early detection of skin cancer to dermatologists in the United States. It offers XTRAC, an ultraviolet light excimer laser system for the treatment of psoriasis, vitiligo, and other skin diseases; and VTRAC Excimer Lamp system for the treatment of psoriasis, vitiligo, atopic dermatitis, and leukoderma. The company also focuses on commercialization of its principal product MelaFind, a non-invasive point-of-care instrument to aid in the detection of melanoma. The company was formerly known as Electro-Optical Sciences, Inc. and changed its name MELA Sciences, Inc. in April 2010. MELA Sciences, Inc. was founded in 1989 and is based in Irvington, New York.

32 Employees
Last Reported Date: 03/30/15
Founded in 1989

mela sciences inc (MELA) Top Compensated Officers

Chief Executive Officer, President and Direct...
Total Annual Compensation: $14.1K
Chief Financial Officer, Secretary and Treasu...
Total Annual Compensation: $194.0K
Compensation as of Fiscal Year 2014.

mela sciences inc (MELA) Key Developments

MELA Sciences, Inc. Announces Unaudited Consolidated Earnings Results for the Second Quarter and Six Months Ended June 30, 2015

MELA Sciences, Inc. announced unaudited consolidated earnings results for the second quarter and six months ended June 30, 2015. For the quarter, the company reported revenue of $611,000 against $225,000 a year ago. Operating loss, before other expense, net was $9,005,000 against $4,258,000 a year ago. Net loss was $7,847,000 or $0.97 per basic and diluted share against net income of $627,000 or $0.12 per basic and diluted share a year ago. LBITDA was $6,687,000 against EBITDA of $813,000 a year ago. Non-GAAP adjusted loss was $2,232,000 against $3,955,000 a year ago. $0.5 million of the second quarter revenues are attributable to the revenues from the XTRAC and VTRAC. For the six months, the company reported revenue of $692,000 against $323,000 a year ago. Operating loss, before other expense, net was $12,637,000 against $8,990,000 a year ago. Net loss was $15,120,000 or $2.08 per basic and diluted share against net loss of $7,353,000 or $1.46 per basic and diluted share a year ago. Net cash used in operating activities was $5,655,000 against $11,039,000 a year ago. LBITDA was $11,317,000 against $6,471,000 a year ago. Non-GAAP adjusted loss was $5,298,000 against $7,762,000 a year ago.

MELA Sciences, Inc. to Report Q2, 2015 Results on Aug 13, 2015

MELA Sciences, Inc. announced that they will report Q2, 2015 results at 4:30 PM, US Eastern Standard Time on Aug 13, 2015

MELA Sciences, Inc., Q2 2015 Earnings Call, Aug 13, 2015

MELA Sciences, Inc., Q2 2015 Earnings Call, Aug 13, 2015

 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
MELA:US $1.20 USD +0.005

MELA Competitors

Market data is delayed at least 15 minutes.

Company Last Change
Lucid Inc $0.55 USD -0.15
Guided Therapeutics Inc $0.06 USD -0.0001
Mauna Kea Technologies €3.05 EUR +0.05
Optiscan Imaging Ltd A$0.05 AUD +0.006
Verisante Technology Inc C$0.09 CAD 0.00
View Industry Companies
 

Industry Analysis

MELA

Industry Average

Valuation MELA Industry Range
Price/Earnings NM Not Meaningful
Price/Sales 7.5x
Price/Book 0.4x
Price/Cash Flow NM Not Meaningful
TEV/Sales NM Not Meaningful
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact MELA SCIENCES INC, please visit www.melasciences.com. Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.